Home  »  Articles   »   Mabuza Welcomes Support to COVID-19 Vaccine Roll-Out Plan

Mabuza Welcomes Support to COVID-19 Vaccine Roll-Out Plan

February 8, 2021

The Presidency

Deputy President David Mabuza has welcomed the support by social partners to government’s Covid-19 vaccine roll-out plan.

The deputy president, as Chairperson of the Inter-Ministerial Committee on Covid-19 vaccines, held meetings with various sectors of society in order to provide an update on government’s roll-out plan for vaccines and to mobilise support from social partners.

In a statement, the presidency confirmed that the meetings at Nedlac included consultations with traditional leaders, inter-faith leaders and social partners.

It was agreed that a “communication toolkit in all official languages will be developed for communities in order to enhance social mobilisation and garner support for vaccination”.

In welcoming the support, the deputy president declared that the positive spirit of cooperation received from traditional leaders, inter-faith leaders and social partners at NEDLAC was encouraging.

“We appreciate that this process does not end here, but it is ongoing engagement and partnership as we work together towards population immunity. We are grateful for the commitment to partner as expressed by social partners at NEDLAC, traditional leaders and inter-faith leaders”, he said.

Meanwhile, the Electronic Vaccine Data System Self-Registration Portal was launched this week.

According to the health minister, Zweli Mkhize, the launch represents the “beginning of a complete vaccination health information system from registration to certification”.

He added that the system has been developed to “ensure that we lay solid foundations for digital health information systems that inform the right national policies and interventions”.

The minister called on all active health workers to self-register on the portal which can be accessed on the url: vaccine.enroll.health.za.

National treasury has also released a fact sheet on indemnification issues in terms of vaccine procurement.

Treasury points out that the health department enters into the vaccine agreements on behalf of government while the finance minister is “required in terms of the PFMA to grant concurrence in respect of the granting of an indemnity in terms of the indemnification provision in the vaccine agreement”.

So far, the finance minister has granted concurrence for the Serum Institute and Pfizer.

Treasury emphasized that it aims to “ensure that the issue of indemnity will not prove to be an obstacle that ultimately inhibits the vital procurement of vaccines”.